Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9351

1

TWFG, Inc. TWFG, Inc. Reports 14.5% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9352

1

Vaxart, Inc. Vaxart Reports Revenue Growth and Improved Operating Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9353

1

DiaMedica Therapeutics Inc. DiaMedica Therapeutics Reports Decreased Assets, Increased R&D Expenses, and Operating Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9354

1

OLD MARKET CAPITAL Corp Old Market Capital Corporation Reports Significant Revenue Growth and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9355

1

Mobile Infrastructure Corp Mobile Infrastructure Corporation Reports 21% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9356

1

electroCore, Inc. electroCore Reports 45% Revenue Growth, Improved Operational Efficiency in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9357

1

Cardio Diagnostics Holdings, Inc. Cardio Diagnostics Reports Mixed Q3 Results, Revenue Growth and Improved Losses Amid Ongoing Liquidity Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9358

1

CADIZ INC Cadiz Inc. Reports Significant Revenue Growth, Improved Operating Results in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9359

1

SONIM TECHNOLOGIES INC Sonim Technologies Reports Significant Revenue and Profit Declines in Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9360

1

BT Brands, Inc. BT Brands Reports 5.2% Revenue Growth, Operating Loss Amid Rising Costs and Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9361

1

Vireo Growth Inc. Vireo Growth Reports 2% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9362

1

Adaptimmune Therapeutics PLC Adaptimmune Reports Significant Revenue Growth and Improved Financials in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9363

1

ZEVRA THERAPEUTICS, INC. Zevra Therapeutics Reports Net Loss of $33.2M, Increased Expenses, and Debt in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9364

1

Palladyne AI Corp. Palladyne AI Corp. Reports Mixed Financial Results, Focuses on AI/ML Software Platform Development

Via official filing (AI summary) | 6 months ago | 0 comments

9365

1

American Oncology Network, Inc. American Oncology Network Reports 39.8% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9366

1

Structure Therapeutics Inc. Structure Therapeutics Reports $33.98M Net Loss, Increases Research and Development Expenses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9367

1

MEDICINOVA INC MediciNova Reports Significant Revenue Decline and Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9368

1

Dermata Therapeutics, Inc. Dermata Therapeutics Reports Net Loss of $3.2M in Q3 2024, Increases Research and Development Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

9369

1

Energous Corp Energous Corporation Reports Q3 2024 Financial Results, Net Loss of $3.4 Million

Via official filing (AI summary) | 6 months ago | 0 comments

9370

1

RenovoRx, Inc. RenovoRx Reports Improved Financials, Raises $17.2M in Private Placements, and Advances Clinical Trials

Via official filing (AI summary) | 6 months ago | 0 comments

9371

1

Microbot Medical Inc. Microbot Medical Inc. Reports Continued Operating Losses and Decrease in Total Assets and Shareholders' Equity

Via official filing (AI summary) | 6 months ago | 0 comments

9372

1

Armata Pharmaceuticals, Inc. Armata Pharmaceuticals Reports 142.7% Increase in Grant Revenue, Net Loss Decrease in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9373

1

NSTS Bancorp, Inc. NSTS Bancorp Reports Improved Q3 Net Loss, Increased Lending and Assets

Via official filing (AI summary) | 6 months ago | 0 comments

9374

1

Enliven Therapeutics, Inc. Enliven Therapeutics Reports Increased Assets, Continued Operating Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9375

1

NATURAL ALTERNATIVES INTERNATIONAL INC Natural Alternatives International Reports Decline in Financial Performance, Net Loss Increases 185%

Via official filing (AI summary) | 6 months ago | 0 comments